• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳头为主型组织学亚型预示肺腺癌患者预后不良。

Papillary predominant histological subtype predicts poor survival in lung adenocarcinoma.

作者信息

Yaldız Demet, Acar Arkın, Örs Kaya Şeyda, Aydoğdu Zekiye, Gürsoy Soner, Yaldız Sadık

机构信息

Department of Thoracic Surgery, Manisa Celal Bayar University, Faculty of Medicine, Manisa, Turkey.

Department of Thoracic Surgy, Dr. Suat Seren Chest Diseases and Thoracic Surgery Training and Research Hospital, Izmir, Turkey.

出版信息

Turk Gogus Kalp Damar Cerrahisi Derg. 2019 Jun 21;27(3):360-366. doi: 10.5606/tgkdc.dergisi.2019.17284. eCollection 2019 Jul.

DOI:10.5606/tgkdc.dergisi.2019.17284
PMID:32082885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7021432/
Abstract

BACKGROUND

This study aims to investigate whether papillary predominant histological subtype can predict poor survival in lung adenocarcinoma.

METHODS

Between January 2005 and December 2016, a total of 80 patients with papillary predominant subtype lung adenocarcinoma (70 males, 10 females; mean age 60.7 years; range, 42 to 79 years) operated in our clinic were included in the study. These patients were compared with those having lepidic, acinar, and mucinous subtypes. Overall and five-year survival rates were evaluated.

RESULTS

Five-year survival was 40.5% in papillary predominant histological subtype, while this rate was 70.9%, 59.0%, and 66.6% in lepidic, acinar, and mucinous subtypes, respectively. Papillary subtype showed significantly poor survival compared to lepidic (p=0.002), acinar (p=0.008), and mucinous subtypes (p=0.048). In Stage 1 disease, it was more evident (papillary, 47.5%, lepidic 86.9% [p=0.001], acinar 69.3% [p=0.040], and mucinous 90.0% [p=0.050]).

CONCLUSION

Our study results suggest that papillary predominant subtype predicts poor survival in lung adenocarcinoma and these cases may be candidates for adjuvant treatment modalities even in the earlier stages of disease.

摘要

背景

本研究旨在调查乳头状为主的组织学亚型是否可预测肺腺癌患者的不良生存情况。

方法

2005年1月至2016年12月期间,纳入在我院接受手术治疗的80例乳头状为主亚型肺腺癌患者(男性70例,女性10例;平均年龄60.7岁;范围42至79岁)。将这些患者与具有鳞屑状、腺泡状和黏液性亚型的患者进行比较。评估总生存率和五年生存率。

结果

乳头状为主组织学亚型的五年生存率为40.5%,而鳞屑状、腺泡状和黏液性亚型的这一比例分别为70.9%、59.0%和66.6%。与鳞屑状亚型(p=0.002)、腺泡状亚型(p=0.008)和黏液性亚型(p=0.048)相比,乳头状亚型的生存率显著较差。在Ⅰ期疾病中,这种差异更为明显(乳头状亚型为47.5%,鳞屑状亚型为86.9% [p=0.001],腺泡状亚型为69.3% [p=0.040],黏液性亚型为90.0% [p=0.050])。

结论

我们的研究结果表明,乳头状为主亚型可预测肺腺癌患者的不良生存情况,即使在疾病早期阶段,这些病例也可能是辅助治疗模式的候选对象。

相似文献

1
Papillary predominant histological subtype predicts poor survival in lung adenocarcinoma.乳头为主型组织学亚型预示肺腺癌患者预后不良。
Turk Gogus Kalp Damar Cerrahisi Derg. 2019 Jun 21;27(3):360-366. doi: 10.5606/tgkdc.dergisi.2019.17284. eCollection 2019 Jul.
2
Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas.切除性肺腺癌中主要组织学亚型的预后影响。
Balkan Med J. 2019 Oct 28;36(6):347-353. doi: 10.4274/balkanmedj.galenos.2019.2019.1.130. Epub 2019 Sep 17.
3
Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.第二主要亚型可预测中恶性浸润性肺腺癌的预后†
Eur J Cardiothorac Surg. 2017 Feb 1;51(2):218-222. doi: 10.1093/ejcts/ezw318.
4
Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.以鳞屑样生长为主的肺腺癌具有良好的预后:淋巴管侵犯发生率低是一个关键因素。
Anticancer Res. 2014 Jun;34(6):3153-6.
5
Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma.微小组织学成分可预测I期以腺泡或乳头为主型肺腺癌切除患者的复发情况。
Front Oncol. 2022 Dec 23;12:1090544. doi: 10.3389/fonc.2022.1090544. eCollection 2022.
6
Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar-predominant lung adenocarcinoma.根据 I 期以腺泡为主型肺腺癌中鳞屑型亚型的比例进行预后评估。
Thorac Cancer. 2021 Jul;12(14):2072-2077. doi: 10.1111/1759-7714.14013. Epub 2021 May 25.
7
The presence of lepidic and micropapillary/solid pathological patterns as minor components has prognostic value in patients with intermediate-grade invasive lung adenocarcinoma.以鳞屑状和微乳头/实性病理模式作为次要成分的情况在中级别浸润性肺腺癌患者中具有预后价值。
Transl Lung Cancer Res. 2022 Jan;11(1):64-74. doi: 10.21037/tlcr-21-934.
8
Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation.表皮生长因子受体突变的 II-III 期肺腺癌中优势亚型的预后价值。
Lung Cancer. 2024 Feb;188:107453. doi: 10.1016/j.lungcan.2023.107453. Epub 2023 Dec 30.
9
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.肺腺癌 IASLC/ATS/ERS 分类的影响:基于 514 例 I 期病例分析的预后亚组和对进一步修订分期的影响。
Mod Pathol. 2011 May;24(5):653-64. doi: 10.1038/modpathol.2010.232. Epub 2011 Jan 21.
10
Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.根据新的肺腺癌分类,IB期患者的生存及EGFR突变与主要组织学亚型的相关性。
World J Surg Oncol. 2014 May 19;12:148. doi: 10.1186/1477-7819-12-148.

引用本文的文献

1
fusion driven () non-small cell lung cancer: a comprehensive genomic profiling study with histologic correlation.融合驱动的()非小细胞肺癌:一项具有组织学相关性的综合基因组分析研究
Front Oncol. 2025 May 16;15:1477910. doi: 10.3389/fonc.2025.1477910. eCollection 2025.
2
Prediction of lung papillary adenocarcinoma-specific survival using ensemble machine learning models.使用集成机器学习模型预测肺乳头状腺癌特异性生存。
Sci Rep. 2023 Sep 8;13(1):14827. doi: 10.1038/s41598-023-40779-1.

本文引用的文献

1
Prognostic factors for stage I lung adenocarcinoma and surgical management of subsolid nodules.Ⅰ期肺腺癌的预后因素及亚实性结节的外科治疗
Turk Gogus Kalp Damar Cerrahisi Derg. 2018 Sep 16;26(4):614-620. doi: 10.5606/tgkdc.dergisi.2018.15846. eCollection 2018 Oct.
2
Clinical Relevance of Different Papillary Growth Patterns of Pulmonary Adenocarcinoma.肺腺癌不同乳头样生长模式的临床相关性
Am J Surg Pathol. 2016 Jun;40(6):818-26. doi: 10.1097/PAS.0000000000000622.
3
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.肺腺癌的亚型分类可预测完全切除术后患者辅助化疗的获益情况。
J Clin Oncol. 2015 Oct 20;33(30):3439-46. doi: 10.1200/JCO.2014.58.8335. Epub 2015 Apr 27.
4
Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma.微乳头模式对IA期肺腺癌的不良预后影响。
Eur J Cardiothorac Surg. 2016 Jan;49(1):293-9. doi: 10.1093/ejcts/ezv058. Epub 2015 Mar 11.
5
New pathologic classification of lung cancer: relevance for clinical practice and clinical trials.肺癌的新病理分类:对临床实践和临床试验的意义。
J Clin Oncol. 2013 Mar 10;31(8):992-1001. doi: 10.1200/JCO.2012.46.9270. Epub 2013 Feb 11.
6
Prognostic significance of predominant histologic pattern and nuclear grade in resected adenocarcinoma of the lung: potential parameters for a grading system.肺腺癌中主要组织学模式和核分级的预后意义:分级系统的潜在参数。
J Thorac Oncol. 2013 Jan;8(1):37-44. doi: 10.1097/JTO.0b013e318276274e.
7
The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.新型组织学国际肺癌研究协会/美国胸科学会/欧洲呼吸学会肺腺癌分类系统是一种与分期无关的生存预测指标。
J Clin Oncol. 2012 May 1;30(13):1438-46. doi: 10.1200/JCO.2011.37.2185. Epub 2012 Mar 5.
8
Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.肺腺癌亚型是否能预测患者生存情况?一项基于新的国际肺癌研究协会/美国胸科学会/欧洲呼吸学会国际多学科肺腺癌分类的临床病理研究。
J Thorac Oncol. 2011 Sep;6(9):1496-504. doi: 10.1097/JTO.0b013e318221f701.
9
Prognostic significance of a solid component in pulmonary adenocarcinoma.肺腺癌中实性成分的预后意义。
Ann Thorac Surg. 2011 Apr;91(4):1051-7. doi: 10.1016/j.athoracsur.2010.11.071.
10
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.肺腺癌 IASLC/ATS/ERS 分类的影响:基于 514 例 I 期病例分析的预后亚组和对进一步修订分期的影响。
Mod Pathol. 2011 May;24(5):653-64. doi: 10.1038/modpathol.2010.232. Epub 2011 Jan 21.